Evidence map›Paper›PMID 31244935›Full record

ArticleTheranostics2019

CD137 promotes bone metastasis of breast cancer by enhancing the migration and osteoclast differentiation of monocytes/macrophages.

Pengling Jiang, Wenjuan Gao, Tiansi Ma, Rongrong Wang, Yongjun Piao, Xiaoli Dong, Peng Wang, Xuehui Zhang, Yanhua Liu, Weijun Su and 3 more

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 104 citations in OpenAlex.

  1. Effects of denosumab treatment on the expression of receptor activator of nuclear kappa-B ligand (RANKL) and TNF-receptor TNFRSF9 after total hip arthroplasty-results from a randomized placebo-controlled clinical trial.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2022
    Trial
  2. Review
  3. Journal of traditional and complementary medicine · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Pengling JiangThird Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Wenjuan GaoSchool of Medicine, Nankai University, 94 Weijin Road, Tianjin, China.
Tiansi MaSchool of Medicine, Nankai University, 94 Weijin Road, Tianjin, China.
Rongrong WangSchool of Medicine, Nankai University, 94 Weijin Road, Tianjin, China.
Yongjun PiaoSchool of Medicine, Nankai University, 94 Weijin Road, Tianjin, China.
Xiaoli DongSchool of Medicine, Nankai University, 94 Weijin Road, Tianjin, China.
Peng WangSchool of Medicine, Nankai University, 94 Weijin Road, Tianjin, China.
Xuehui ZhangTianjin's Clinical Research Center for Cancer, Tianjin, China.
Yanhua LiuSchool of Medicine, Nankai University, 94 Weijin Road, Tianjin, China.
Weijun SuSchool of Medicine, Nankai University, 94 Weijin Road, Tianjin, China.
Rong XiangSchool of Medicine, Nankai University, 94 Weijin Road, Tianjin, China.
Jin ZhangThird Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Na LiSchool of Medicine, Nankai University, 94 Weijin Road, Tianjin, China.
Nankai University · CNTianjin Medical University Cancer Institute and Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cell DifferentiationCell MovementAnimalsBone NeoplasmsBreast NeoplasmsCell LineDisease Models, AnimalFos-Related Antigen 1MiceModels, BiologicalMonocytesNeoplasm MetastasisOsteoclastsProto-Oncogene Proteins c-fosTumor Necrosis Factor Receptor Superfamily, Member 9Up-RegulationFos-Related Antigen 1Proto-Oncogene Proteins c-fosTumor Necrosis Factor Receptor Superfamily, Member 9anti-CD137 antibodybone metastasisbreast cancerFra1liposomal nanoparticlesmetastatic niche.

Identifiers

PMID31244935
PMCPMC6568184
OpenAlexW2947621671

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.